Jeffrey B Kindler, Director, on August 26, 2026, sold 185,000 shares in Precigen (PGEN) for $1,376,400. Following the Form 4 filing with the SEC, Kindler has control over a total of 17,100 common shares of the company, with 17,100 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1356090/000095010326013201/xslF345X05/ownership.xml